Navigation Links
Job picture for 2006 chemistry grads reasonably good, C&EN reports
Date:12/3/2007

The job situation for 2006 chemistry graduates remains reasonably good and similar to what it was in the previous two years, but full-time jobs remain less plentiful than they were for graduates during the second half of the booming 1990s, reports the American Chemical Society (ACS).

The median salary for inexperienced bachelors graduates with full-time, permanent employment and less than a year of technical work before graduation remained unchanged at $35,000, according to the latest ACS annual survey of the employment status and salaries of new chemistry graduates. The median is the point at which half of the salaries are above a certain point and half are below that point. The survey appeared in the Dec. 3 issue of Chemical & Engineering News (C&EN), the Societys weekly newsmagazine.

Masters graduates, meanwhile, posted a $2,400, or 5 percent one-year gain to $47,400, while the median salary for Ph.D. graduates dipped all the way to $60,000 from $72,400 for 2005 graduates, a decline of 17 percent.

Two-year salary changes for bachelors and masters graduates were somewhat nearer the norm, CEN reports. Salaries for 2006 bachelors graduates were 8 percent higher than for those who graduated in 2004, while for masters grads the increase was 9 percent.

Salaries for 2006 Ph.D. grads dropped 8 percent from their 2004 counterparts.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Genes, brain chemistry may dictate nicotine cravings, says CU-Boulder study
2. Histochemistry is the golden standard in the diagnosis of carcinosarcomas
3. ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies
4. The Good, the Bad, and the Ugly of the Nunez/Perata Health Plan
5. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
6. Haemacure Reports Third Quarter 2007 Results
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
11. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 2Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 3Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 4Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 5Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 6Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 7Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 8Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 9Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 10Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 11Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 12Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 13Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 14Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 15Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 16Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 17Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 18Health News:Rheumatoid Arthritis May Harm Gums 2Health News:Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Management Integrated with SAP(R) 2Health News:NASA-Enhanced Dust Storm Predictions to Aid Health Community 2Health News:NASA-Enhanced Dust Storm Predictions to Aid Health Community 3
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Brain difference in psychopaths identified 9468 1Brain difference in psychopaths identified 9468 2Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 1Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 2Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 3Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 4Office of National Drug Control Policy Taps RIESTER creative for Use in National Anti Meth Campaign 53622 1Office of National Drug Control Policy Taps RIESTER creative for Use in National Anti Meth Campaign 53622 2